Adnkronos "Research is currently focusing on an important aspect: trying to understand the mechanisms that make patients resistant to available treatments and identifying biomarkers that can effectively help us better select patients, avoiding unnecessary toxicity for those who will not benefit." This was stated by Anna Maria Di Giacomo, councilor of the Italian Melanoma Intergroup, at the IMI national congress in Bologna, speaking on the main directions of melanoma research.
https://www.youtube.com/watch?v=BbFBEjp5dD4
Continue on the app
The news of your city, in real time.
Open in app